Cargando…
Waning of SARS-CoV-2 booster viral-load reduction effectiveness
The BNT162b2 COVID-19 vaccine has been shown to reduce viral load of breakthrough infections (BTIs), an important factor affecting infectiousness. This viral-load protective effect has been waning with time post the second vaccine and later restored with a booster shot. It is currently unclear thoug...
Autores principales: | Levine-Tiefenbrun, Matan, Yelin, Idan, Alapi, Hillel, Herzel, Esma, Kuint, Jacob, Chodick, Gabriel, Gazit, Sivan, Patalon, Tal, Kishony, Roy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897467/ https://www.ncbi.nlm.nih.gov/pubmed/35246560 http://dx.doi.org/10.1038/s41467-022-28936-y |
Ejemplares similares
-
SARS-CoV-2 RT-qPCR Test Detection Rates Are Associated with Patient Age, Sex, and Time since Diagnosis
por: Levine-Tiefenbrun, Matan, et al.
Publicado: (2022) -
Pregnancy Course of 10 Women Diagnosed with Chronic Lymphocytic Leukemia
por: Tadmor, Tamar, et al.
Publicado: (2023) -
Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents
por: Prunas, Ottavia, et al.
Publicado: (2022) -
Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
por: Patalon, Tal, et al.
Publicado: (2022) -
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study
por: Yechezkel, Matan, et al.
Publicado: (2023)